发明人沈红梅,周伟,唐晓军. "Method for the Synthesis of (S,E)-2-Amino-5-(2,3-dimethylguanidino)pentanoic Acid-13C5" [P]. 中国发明专利, 专利号 CN 110693855 A, 授权公告日 2020-08-08.
Sørensen M, Kowalski A, Björnsson E. "A Process for Preparing High-Purity (S,E)-2-Amino-5-(2,3-dimethylguanidino)pentanoic Acid-13C5" [P]. European Patent, EP 3186266 A1, 2020-01-20.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 2-氨基-5-(2,3-二甲基胍基)戊酸-13C5 in Pharmaceutical Formulations". Sci. Total Environ., 2019, 1577, (4), 9293-9322.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of 2-氨基-5-(2,3-二甲基胍基)戊酸-13C5 as an Impurity". Talanta, 2018, 1806, 2804-2831.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of (S,E)-2-Amino-5-(2,3-dimethylguanidino)pentanoic Acid-13C5 Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2024, 786, 9329-9344.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate 2-氨基-5-(2,3-二甲基胍基)戊酸-13C5 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2016, 1075, 6481-6496.